Delivery Order SPE2DB22D1106-SPE2DB24FFAN3

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the PEDVAXHIB vaccine in 0.5 ml vials. The $7,268.40 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide PEDVAXHIB vaccine vials 0.5 mL to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,231.40 and is a firm fixed-price contract with a completion date of May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the PEDVAXHIB vaccine vial (0.5 mL) to the U.S. government. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,014.68 and a completion date of July 11, 2024. This is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PEDVAXHIB vaccine vials. The contract has a ceiling value of $5,256.90 and a completion date of April 17, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,085.49 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials (0.5 mL). The contract has an ultimate completion date of June 24, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PEDVAXHIB vaccine vials (0.5 ml) with a ceiling value of $1,115.70. It is a Firm Fixed Price delivery order contract with a completion date of June 12, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) for the delivery of PEDVAXHIB vaccine vials. The contract has a ceiling value of $5,256.90 and a completion date of November 24, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,329.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of August 14, 2023 and is structured as a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the PEDVAXHIB vaccine in 0.5 milliliter vials. The $2,405.65 contract has a completion date of June 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that enables the company to supply a wide range of pharmaceutical products and...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAN3
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide the PEDVAXHIB vaccine in 0.5mL vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,509.04 and a completion date of July 8, 2024. The contract type is a Delivery Order under a Firm Fixed Price pricing structure.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current contract award is a specific order under this larger IDC.

There is no set-aside designation for this contract award.

Generated 10/4/24, 9:23 AM